Osteochondroprogenitor can be found between MSCs and the terminally differentiated osteoblasts and chondrocytes. Via different signalling molecules and combinations the osteochondroprogenitor will differentiate into either osteoblasts or chondrocytes. (which may also be known as Cbfa1), and Osx (a zinc finger containing transcription factor) are necessary for osteochondroprogenitor cells to differentiate into the osteoblast cell lineage. These factors also have a role in
hypertrophic chondrocyte maturation.
B-catenin β-catenin of the canonical
Wnt signalling pathway plays a role in cell fate determination, as it is critical for osteoblastogenesis, and the differentiation of chondrocytes into osteoblasts. Knock out of the entire pathway results in early
embryonic death, therefore most research of this nature utilised conditional knockouts of the pathway. TGF-β determines and regulates cell lineages during endochondral ossification through Sox9 and Runx2 signalling pathways. TGF-β will act as a stimulator of chondrogenesis, and an inhibitor of osteoblastic differentiation, by blocking the Runx2 factor through
Smad3 activation. Sox9 stimulates differentiation into chondrocytes. Sox9 blocked osteochondroprogenitor cells were found to express osteoblast marker genes, reprogramming the cells into the osteoblastic lineage. Loss of TGF-β signalling will lead to reduced Sox9 activity, but not prevent it completely, suggesting that there must be other factors and signalling pathways regulating Sox9 activity. Once Sox9 activity is lost, differentiation into the osteoblastic lineage dominates. ==Embryonic development==